Effects on blood lipids of a blood pressure–lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial123
KEY WORDS
Cited by (0)
- 1
From the Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; the Endocrine-Hypertension Division, Brigham & Women’s Hospital, Harvard Medical School, Boston; Kaiser Permanente, Center for Health Research, Portland, OR; the Pennington Biomedical Research Center, Louisiana State University, Baton Rouge; the Welch Center for Prevention, Johns Hopkins University, Baltimore; the Sarah W Stedman Center for Nutritional Studies, Duke University School of Medicine, Durham, NC; Merck & Co, Boston; and the Geriatric Research, Education and Clinical Center, VA Medical Center, Durham, NC.
- 2
Supported by NHLBI Cooperative Agreements U01-HL50968, U01-HL50972, U01-HL50977, U01-HL50981, and U01-HL50982; by RR00722 and RR02635; and by a supplement from the NIH Office of Research and Minority Health.
- 3
Address correspondence to E Obarzanek, Division of Epidemiology and Clinical Applications, National, Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 8136, MSC 7936, Bethesda, MD 20892-7936. E-mail: [email protected].